COVID-19 (eBook, PDF)

From Bench to Bedside
Redaktion: Barh, Debmalya; Lundstrom, Kenneth

• Format: PDF

Produktbeschreibung

The COVID-19 pandemic has affected the entire world in an unprecedented way and this book provides an overview of the historical facts as well as ongoing approaches to tackle the COVID-19 pandemic.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis
• Seitenzahl: 238
• Erscheinungstermin: 3. März 2022
• Englisch
• ISBN-13: 9781000510089
• Artikelnr.: 63407204

Autorenporträt

Dr. Debmalya Barh is currently a Visiting Full Professor (Titular, Grade-E) at the Department of Genetics, Ecology and Evolution, Institute of Biological Sciences (ICB), Federal University of Minas Gerais (UFMG), Brazil. He is also an honorary Scientist at Institute of Integrative Omics and Applied Biotechnology (IIOAB), India. Dr. Kenneth Lundstrom is currently the CEO of PanTherapeutics in Lausanne, Switzerland.He serves on editorial boards of various journals including Biomedicines and Viruses, and acts as Editor-in-chief for Frontiers in Translational Virology.

Inhaltsangabe

Chapter 1 Coronavirus epidemics and the current COVID-19 pandemic
Chapter 2 Biology of Coronaviruses and Predicted Origin of SARS-CoV-2
Chapter 3 Therapeutic Challenges in COVID-19
Chapter 4 Prevention and Control Strategies for COVID-19 Pandemic
Chapter 5 Global Focus and Interdisciplinary Approaches in COVID-19
Research and Their Outcomes
Chapter 6 The evolution of COVID-19 diagnostics
Chapter 7 Drug repurposing and novel antiviral drugs for COVID-19
management
Chapter 8 Convalescent Plasma and Antibody Therapy in COVID-19
Chapter 9 Application Stem Cell and Exosome Based Therapy in COVID-19
Chapter 10 Host and Pathogen-Specific Drug Targets in COVID-19
Chapter 11 Computational biology and bioinformatics in anti-SARS-CoV-2 drug
development
Chapter 12 Nanomaterials in COVID-19 drug development
Chapter 13 Vaccine Development Strategies and the Current Status of
COVID-19 Vaccines
Chapter 14 Clinical trials of COVID-19 therapeutics and vaccines: history,
current status, and limitations
Chapter 15 Lessons Learned from COVID-19 and Their Implementations for
Future Pandemics